Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF)
SG&A Expense Growth
0.00%
Quarterly · Period ending:
CANF SG&A Expense Growth
Latest reported0.00%period ending
Latest reported0.00%period ending
CANF Quarterly SG&A Growth (QoQ) (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
CANF sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 0% | |
| -10.6516% | |
| 0% | |
| -22.7492% | |
| 0% | |
| 35.7423% | |
| 0% | |
| -0.1967% | |
| 0% | |
| 5.6094% | |
| -5.2493% | |
| 22.1154% | |
| -26.3282% | |
| 2.5424% | |
| 11.471% | |
| -9.854% | |
| 9.0186% | |
| -33.3333% | |
| 37.5912% | |
| -6.1644% | |
| -13.7795% | |
| 25.8984% | |
| 17.1263% | |
| -8.3777% | |
| 6.9701% | |
| -3.9617% | |
| -17.4746% | |
| 15.7963% | |
| 35.097% | |
| -14.6084% | |
| 17.1076% | |
| -37.8289% | |
| 0.5513% | |
| 13.6127% | |
| 15.5315% | |
| 6.1488% | |
| -16.2692% | |
| 29.9884% | |
| -25.4832% | |
| 19.7325% | |
| 7.2065% | |
| -35.595% | |
| 96.7974% | |
| -19.0949% | |
| -2.5534% | |
| -25.7795% | |
| 63.1552% | |
| -30.1345% | |
| -12.023% | |
| -53.9882% | |
| 116.3021% | |
| -19.9371% | |
| 40.3317% | |
| -18.9726% | |
| 87.0528% | |
| -17.7128% | |
| 21.0526% | |
| -3.3766% | |
| 9.5381% | |
| -2.0042% | |
| 3.0951% | |
| -19.5792% | |
| 60.21% | |
| 0% |